Performance analysis of Summit Therapeutics (SMMT)
Annual Return
Over the past 3 years, SMMT has had an average annual return of +102.82%, outperforming the benchmark SPY, which returned +22.45% annual.
Over the past 5 years, SMMT has had an average annual return of +13.53%, underperforming the benchmark SPY, which returned +13.88% annual.
Over the past 10 years, SMMT has had an average annual return of +5.76%, underperforming the benchmark SPY, which returned +15.44% annual.
Since Mar 5, 2015, SMMT has had an average annual return of +3.54%, underperforming the benchmark SPY, which returned +13.91% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -13.84% | -1.99% | +583.80% | -38.60% | +57.99% | -42.76% | +193.76% | +39.06% | -89.62% | +29.44% | -25.57% | +12.86% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.21% | +14.57% | +14.28% | +13.19% | -18.27% | -14.08% | -13.84% | ||||||
| 2025 | +20.48% | -3.77% | -6.77% | +25.04% | -24.48% | +16.83% | +23.92% | -10.12% | -12.83% | -8.47% | -5.39% | -2.23% | -1.99% |
| 2024 | +50.21% | +15.80% | -8.80% | -5.07% | +120.97% | -10.18% | +38.46% | +20.18% | +68.72% | -15.12% | -0.70% | -3.33% | +583.80% |
| 2023 | -16.47% | -49.31% | -2.77% | -24.58% | +23.55% | +53.94% | -16.32% | -22.85% | +15.41% | +3.76% | +4.62% | +28.56% | -38.60% |
| 2022 | -18.22% | +24.55% | -10.60% | -35.11% | -16.35% | -24.83% | +1.02% | +18.87% | -0.85% | -8.39% | -26.64% | +431.34% | +57.99% |
| 2021 | +48.09% | -2.72% | -13.29% | +8.51% | +22.76% | -4.60% | -1.75% | +8.73% | -37.13% | +2.99% | -1.56% | -47.04% | -42.76% |
| 2020 | -4.39% | -9.79% | +71.79% | +58.21% | +7.74% | -26.48% | +21.89% | -4.70% | -0.30% | -4.95% | +37.61% | +4.44% | +193.76% |
| 2019 | +15.59% | +72.95% | -20.43% | -3.56% | -13.86% | -16.76% | +4.27% | +1.31% | +33.92% | -7.85% | -9.08% | +6.66% | +39.06% |
| 2018 | +23.92% | -14.71% | +10.15% | +1.01% | +2.46% | -81.65% | -6.11% | +2.17% | -5.51% | -23.45% | -23.50% | -11.52% | -89.62% |
| 2017 | +22.32% | +16.61% | +8.72% | -17.13% | +1.09% | +2.43% | +22.73% | -7.94% | -2.49% | -18.09% | +14.50% | -5.87% | +29.44% |
Drawdown analysis of Summit Therapeutics (SMMT)
The maximum drawdown for the SMMT was -95.75%, occurring on Dec 1, 2022. Recovery took 443 trading sessions.
The current SMMT drawdown is -58.94%.
Since Mar 5, 2015 SMMT has experienced the following drawdowns:
- 50% or more: 3 times
- 40% or more: 5 times
- 30% or more: 5 times
- 20% or more: 5 times
- 10% or more: 6 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.75% | Sep 11, 2017 | 1316 | Dec 1, 2022 | 443 | Sep 9, 2024 | 1759 |
| -62.26% | Apr 24, 2025 | 197 | Feb 5, 2026 | Ongoing | Ongoing | Ongoing |
| -59.80% | Apr 6, 2015 | 366 | Sep 15, 2016 | 13 | Oct 4, 2016 | 379 |
| -47.89% | Sep 13, 2024 | 141 | Apr 8, 2025 | 10 | Apr 23, 2025 | 151 |
| -43.41% | Oct 4, 2016 | 60 | Dec 29, 2016 | 151 | Aug 7, 2017 | 211 |
| -16.79% | Aug 7, 2017 | 5 | Aug 14, 2017 | 17 | Sep 7, 2017 | 22 |
| -7.31% | Mar 23, 2015 | 4 | Mar 27, 2015 | 1 | Mar 30, 2015 | 5 |
| -7.06% | Mar 10, 2015 | 2 | Mar 12, 2015 | 4 | Mar 18, 2015 | 6 |
| -1.37% | Sep 7, 2017 | 1 | Sep 8, 2017 | 1 | Sep 11, 2017 | 2 |
| -1.18% | Sep 10, 2024 | 1 | Sep 11, 2024 | 1 | Sep 12, 2024 | 2 |
| -0.67% | Mar 19, 2015 | 1 | Mar 20, 2015 | 1 | Mar 23, 2015 | 2 |